Jim Hinton, CEO of Baylor Scott & White Health, on a concerted approach to affordability

Jan 05, 2018 - 05:49 AM
 

Related News Articles

Headline
Weather threats to drug production facilities examined in study
A JAMA study published Aug. 20 found that nearly 63% of all U.S. drug production facilities from 2019 through 2024 were in counties where a weather disaster…
Headline
B. Braun Medical recalls certain IV fluids
B. Braun Medical has voluntarily recalled two lots of Lactated Ringer’s Injection USP 1000 mL and 0.9% Sodium Chloride Injection USP 1000 mL IV fluids due to…
Headline
Administration orders six-month stockpile of ingredients for domestic drug supply 
The White House Aug. 13 released an executive order directing the Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness…
Headline
FDA recalls filters for potential of serious harm; voluntary notice issued for soaps, cleansers
The Food and Drug Administration has identified a Class I recall of Draeger SafeStar and TwinStar Filters due to a risk of misleading carbon dioxide readings.…
Headline
FDA announces end to IV saline solution shortage 
The Food and Drug Administration Aug. 8 announced an end to the national shortage of sodium chloride 0.9% IV solutions products. The agency said it continues…
Headline
FDA announces new program to boost domestic drug manufacturing 
The Food and Drug Administration Aug. 7 announced a new program to help improve the domestic pharmaceutical supply chain by increasing regulatory…